Skip to main navigation Skip to search Skip to main content

The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection

  • E. H. C. J. Buster
  • , B. C. Baak
  • , C. M. Bakker
  • , U. H. W. Beuers
  • , J. T. Brouwer
  • , J. P. H. Drenth
  • , K. J. van Erpecum
  • , B. van Hoek
  • , P. Honkoop
  • , M. J. Kerbert-Dreteler
  • , G. H. Koek
  • , K. M. J. van Nieuwkerk
  • , H. van Soest
  • , B. W. van der Spek
  • , A. C. I. T. L. Tan
  • , J. M. Vrolijk
  • , H. L. A. Janssen
  • , G.H. Hoek

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In 2008, the Netherlands Association of Gastroenterologists and Hepatologists (Nederlands Vereniging van Maag-Darm-Leverartsen) published the Dutch national guidelines for the treatment of chronic hepatitis B virus infection. New insights into the treatment of chronic hepatitis B with relevance for clinical practice have been adopted in these concise, revised guidelines. The most important changes include the choice of initial antiviral therapy, licensing of tenofovir for the treatment of chronic hepatitis B and the management of antiviral resistance
Original languageEnglish
Pages (from-to)381-385
JournalNetherlands journal of medicine
Volume70
Issue number8
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection'. Together they form a unique fingerprint.

Cite this